2/1/2021 4:06:14 PM
Vertex Pharma Q4 EPS $2.30 Vs. $2.23 Year Ago
1/28/2021 4:14:22 PM
Vertex Announces FDA Clearance Of Investigational New Drug Application For VX-880 For Treatment Of Type 1 Diabetes
12/28/2020 8:08:34 AM
Vertex Expects To Approve Cystic Fibrosis TRIKAFTA Medicine By Health Canada In H1 Of 2021
12/28/2020 8:03:29 AM
Vertex : Canada Accepts New Drug Submission For Triple Combination Medicine For Treatment Of CF For Priority Review
12/22/2020 8:34:20 AM
Skyhawk Therapeutics, Vertex Announce Strategic Research Collaboration And Licensing Agreement
11/27/2020 3:10:15 AM
Vertex: European Commission Grant Approval Of Label Extension For SYMKEVI With KALYDECO For Cystic Fibrosis Age 6-11
11/13/2020 4:12:47 PM
Vertex Recommends Rejection Of 'Mini-Tender' Offer From TRC Capital Investment Corp
11/5/2020 4:05:08 AM
Vertex Pharma: European Commission Grants Approval Of Label Extension For KALYDECO Granules
10/29/2020 4:23:37 PM
Vertex Pharma Q3 EPS $2.53 Vs. $0.22 Year Ago